HydroCision, Inc. Elects Two New Members to Board of Directors

Andover, MA, November 17, 2004 HydroCision Inc. today announced that it has elected two new members to its board of directors – Lew Bennett and Alastair J.T. Clemow, Ph.D.   The two new members were added to the company’s board to provide in-depth technical knowledge and industry experience in the spine market, the company’s primary area of focus.   The appointments are effective immediately.

Mr. Bennett currently serves on the board of directors of several organizations including, SpineMark, CoDon and PAS Asset Acquisition.   A 45-year veteran of the medical industry, Lew has held senior executive positions with companies in the orthopedic and spine businesses including, Executive Vice President and Officer-Board Member of NuVasive, Inc.; Executive Vice President and Corporate Officer of Sofamor Danek (now a division of Medtronic, Inc.); President of the General Medical Division of Smith & Nephew; and President of Dillion Manufacturing. In addition, he was one of the founders of Howmedica (now Stryker Orthopedics).

  “We are delighted that Lew Bennett has agreed to join HydroCision’s board of directors,” stated Ben Bronstein, M.D., a current board member and Managing Director at Zero Stage Capital.   "His customer and industry knowledge will be invaluable to HydroCision as it launches its innovative SpineJet™ products into the spine market.   We are honored to have on our board an executive of Lew’s experience and stature in the medical device industry.”

Dr. Clemow is currently the President and CEO of Nexgen Spine Inc.   He has served in numerous senior management positions including President & CEO of Gelifex, Inc.; Vice President of Worldwide New Business Development at Ethicon Endo-Surgery (a division of Johnson & Johnson); Vice President of New Business Development, Johnson and Johnson Professional Inc.; and Director of R&D, Johnson and Johnson Orthopaedics. Dr. Clemow holds B.Sc. and Ph.D. degrees in Metallurgy from the University of Surrey, and an MBA in Finance from Columbia University.

  “Alastair Clemow has tremendous technical and clinical knowledge in the spine and orthopedic businesses”, said Jeff Barnes, a director and general partner at Oxford Bioscience Partners. “His knowledge will add real value in assisting the company to better define its technical and business strategies.   In addition, he will help the Board make the most appropriate decisions to achieve shareholder value.   Dr. Clemow will be a great addition to HydroCision’s board.”

Tim Moutafis, HydroCision’s founder and Chief Technology Officer, has resigned from the board of directors; he will be a board observer and continue in his role of Chief Technology Officer.

  “We look forward to the energy and wisdom that Dr. Clemow and Mr. Bennett will be adding as members the board ”, stated Doug Daniels, President and CEO of HydroCision. “Their many years of experience in the spine business will provide the organization with the in-depth knowledge and insight to take the company to the next stage of   development.   We now have a world-class spine board to go along with an industry leading technology. We recognize the extraordinary technical developments that Tim Moutafis has provided the HydroCision organization. We look forward to Tim’s continued contribution to technical advances in the SpineJet products.”

About HydroCision

HydroCision (www.hydrocision.com), founded in 1994, is the leading developer, manufacturer, and marketer of fluidjet based surgical tools.   HydroCision believes its proprietary fluidjet technology is the basis of a new surgical modality, “HydroSurgery”, because of its compelling features and versatility. The company is developing a broad range of fluidjet-based products to meet the needs of multiple surgical specialties including orthopedics, spine surgery, wound care, plastic surgery, ENT, and obstetrics and gynecology.

HydroCision, SpineJet, and HydroDiscectomy are registered trademarks of HydroCision, Inc. SpineJet Resector, SpineJet Resector XT, SpineJet XL, SpineJet MicroResector, The Leader in HydroSurgery, The Better Way to Operate, and HydroDrive Technology are trademarks of HydroCision, Inc.

Company Contacts:

Douglas J. Daniels

President & CEO

ddaniels@hydrocision.com

978-474-9300 x136

Joseph Plante

Vice President & General Manager

jplante@hydrocision.com

978-474-9300 x135